|
0
|
|
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
(academic.oup.com)
|
Streinu-Cercel A
…
Gonzalez Del Castillo JM
Clinical Infectious Diseases
2026-02-09
|
#covid-19
#clinical trial
#antiviral
#nucleoside
|
|
0
|
|
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity.
(academic.oup.com)
|
Zhang W
…
Hammond J
Clinical Infectious Diseases
2026-02-09
|
#covid-19
#clinical trial
#antiviral
#viral rebound
|
|
0
|
|
The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic Preparedness.
(academic.oup.com)
|
Draghia-Akli R
…
Neyts J
Clinical Infectious Diseases
2026-02-09
|
#infection
#antiviral
#pandemic
#drug development
|